98%
921
2 minutes
20
The use of copro-DNA detection methods for the diagnosis of canine Echinococcus multilocularis infection was evaluated with a focus on DNA extraction techniques: two commercial kits and a modified alkaline-sodium dodecyl sulfate (SDS) technique. Dog feces (0.2 g) mixed with a protoscolex or with 1 or 10 eggs of E. multilocularis were subjected to DNA detection following extraction by these methods. DNA was extracted from all protoscolex samples by all methods, but success for samples with eggs depended on extraction technique with the modified technique showing success on all samples. Following experimental infection of dogs, copro-DNA was successfully extracted from fecal samples (0.2 g) of dogs in the patent period by all methods. In the prepatent period, PCR testing of feces subsamples (0.2 g) extracted by each technique was positive at a rate of 79.6-94.4%. Extraction by the modified technique with fecal samples of over 1 g showed detection of copro-DNA in all samples in both the patent and prepatent periods, and it produced reproducible detection in the addition recovery test using feces from 72 different domestic dogs. As copro-DNA was detected for at least 1 day following deworming with administration of anthelmintic drugs in experimentally infected dogs, diagnostic deworming might be useful for clinical examination. Using the present detection method can provide quick and accurate diagnosis of canine E. multilocularis infection, which with prompt management and treatment of infected dogs can prevent pet owners from becoming infected and prevent echinococcosis from spreading into non-endemic areas.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00436-017-5514-y | DOI Listing |
Curr Microbiol
September 2025
Department of Diagnostic Medicine and Pathobiology, Rowan University, Glassboro, NJ, USA.
Staphylococcus pseudintermedius is an opportunistic pathogen that is largely associated with canine hosts but is becoming more widely recognized as a zoonotic pathogen. Understanding its genetic and phenotypic properties, such as virulence factors and antimicrobial resistance (AMR) profiles, is critical for infection control and vaccine development. In this study, we isolated and molecularly characterized three S.
View Article and Find Full Text PDFVet Clin North Am Small Anim Pract
September 2025
Department of Clinical Sciences, School of Veterinary Medicine, Colorado State University, 300 West Drake Road A201, Fort Collins, CO 80525, USA. Electronic address:
Immune-mediated chronic hepatitis is a common cause of chronic hepatitis in dogs. The clinical presentation, laboratory work, and imaging results are variable and not specific. Many dogs are subclinical in the early stages of disease.
View Article and Find Full Text PDFJ Vet Intern Med
September 2025
Department of Clinical Sciences, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran.
Background: Iron-limited erythropoiesis (ILE) is a common condition in dogs and cats, which can lead to anemia; therefore, monitoring with erythrocyte and reticulocyte indices is recommended.
Objectives: To compare the values of mean corpuscular volume (MCV), mean reticulocyte volume (MCVr), and reticulocyte hemoglobin content (CHr) in dogs and cats with ILE.
Methods: Systemative review and meta-analysis.
J Vet Intern Med
September 2025
Ecole Nationale Veterinaire d'Alfort-CHUV-AC-IMRB, Maisons-Alfort, France.
Background: Immune-mediated polyarthritis (IMPA) is a joint disease common in dogs. Although its prognosis is generally favorable, relapses are frequent, and predictive factors for relapse remain poorly characterized.
Objectives: To evaluate the outcome of medical management of IMPA in dogs and identify predictive factors for relapse.
Stem Cells Dev
September 2025
Safari Veterinary Care Centers, Safari Stem Cell Inc, League City, Texas, USA.
This study evaluates the clinical efficacy and safety of intravenous allogeneic mesenchymal stem cell (MSC) therapy as an adjunct to standard immunosuppressive treatment in dogs diagnosed with primary immune-mediated hemolytic anemia (IMHA), particularly in cases with inadequate response to conventional immunosuppressive protocols. A total of 157 client-owned dogs with IMHA received MSC therapy at Safari Veterinary Care Center or collaborating clinics. A core cohort of 43 dogs met strict inclusion criteria: confirmed primary IMHA, no significant comorbidities, and receipt of at least two MSC treatments.
View Article and Find Full Text PDF